From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Eden – a question from the Deputy Sheriff to m’learned friends of the ShareProphets community

By Nigel Somerville, the Deputy Sheriff of AIM | Sunday 7 May 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Noting recent coverage of AIM-listed Eden Research (EDEN) and its, ahem, “interesting” funding arrangements with Terpenetech here on ShareProphets I have a question: given that it appears that Eden is the only holder of paid-up shares in Terpenetech, does that not mean that Eden holds the only (currently) valid voting rights? And if that is the case, is not Eden in fact the ultimate controlling party? And if that is the case, should Terpenetech be viewed as a 100% owned and controlled entity of Eden - a subsidiary, therefore, and have to release full audited accounts?


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 14:05:37